Patent · US Active

Method for treating schizophrenia and related diseases

US8735397B2 · kind B2 · utility

0Cited by
4References
11Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 28, 2011
Grant dateMay 27, 2014
Priority date
Expiry dateDec 16, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a method for treating schizophrenia and/or related diseases comprising administering lurasidone and a mGluR2 ligand to a mammal in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.